S&P 500
5,975.13
+0.7%
+$39.19
DJI
42,512.17
+0.5%
+$206.69
NASDAQ
19,441.51
+1.0%
+$198.90
Bitcoin
106,216.00
+1.9%
+1,999.29
AAPL
$203.06
+0.7%
+$1.36
AMZN
$207.54
+0.4%
+$0.89
GOOG
$169.14
-0.7%
-$1.23
META
$670.29
-0.1%
-$0.61
MSFT
$462.85
+0.2%
+$0.88
NVDA
$141.72
+3.2%
+$4.34
TSLA
$354.18
+3.4%
+$11.49
Bioasis Technologies (OTC: BIOAF)
$0.00
(0.0%)
$0.00
Price as of May 21, 2025, 11:45 a.m. ET
Bioasis Technologies Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
Bioasis Technologies Company Info
biOasis Technologies, Inc. operates as a biopharmaceutical company. It focuses on research and development for the diagnosis and treatment of neurological disease and disorders such as brain cancers, neurodegenerative diseases, and metabolic disorders. Its products include the Transcend program as its proprietary carrier, p97 and imaging agents across the blood brain barrier. The company was founded by Robin B. Hutchison on November 3, 2006 and is headquartered in New Haven, CT.
News & Analysis
No articles found.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.